The course of emotional distress and late mortality following myocardial infarction: Implications for depression screening and treatment

Carney, Robert M.

doi:10.1177/2047487319845122

Cited by 1 publication

(1 citation statement)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Similarly, knowing a patient is depressed should alert the cardiologist that more effort may be needed to help the patient to maximize the benefits of treatment. 23 The question therefore arises concerning the type of additional treatments that should be implemented to improve the mental state of CAD patients. To date, only one RCT focusing on CAD patients found that treating depression by pharmacotherapy improved event-free survival, 24 but all the major trials have found that patients whose depression improved had longer event-free survival than those who continued to report significant depression symptoms.…”

Section: Discussionmentioning

confidence: 99%

Immersive Virtual Reality Therapy as a Support for Cardiac Rehabilitation: A Pilot Randomized-Controlled Trial

Szczepańska-Gieracha

Jóźwik

Cieślik

et al. 2021

Cyberpsychology, Behavior, and Social Networking

View full text Add to dashboard Cite

Depression and anxiety can significantly reduce the effectiveness of cardiac rehabilitation (CR). Several studies have assessed the effectiveness of virtual reality (VR)-based interventions for symptoms of anxiety and depression; however, they do not relate to patients with heart disease. The aim of this study was to assess the effects of VR therapy on the mental state of patients with coronary artery disease (CAD). Thirty-four CAD patients with elevated anxiety or depression symptoms were recruited. After randomization, 17 participants were assigned to the intervention group, and 17 to the control group. Both groups underwent standard CR for outpatients. In the intervention group, eight VR therapy sessions were applied. In the control group, eight sessions of Schultz' Autogenic Training were applied. To assess patient mental states, Hospital Anxiety and Depression Scale (HADS) and Perception of Stress Questionnaire (PSQ) were used, before and after 4 weeks of CR. In the intervention group, a significant decrease in HADS score was observed (19.46 pretreatment vs. 15.73 post-treatment, p = 0.003), HADS-Anxiety subscale decreased by 16.0 percent (p = 0.01) and HADS-Depression by 23.0 percent (p = 0.003). Similarly, a significant decrease in PSQ was recorded at 12.8 percent (64.73 vs. 56.47, p = 0.03). In the control group, HADS and PSQ data did not change. VR therapy significantly reduced the severity of depressive symptoms, anxiety, and stress levels in CAD patients undergoing CR. Immersive VR therapy effectively supports the CR of individuals with anxiety-depressive symptoms. ClinicalTrials.gov (NCT04045977)

show abstract

Section: Discussionmentioning

confidence: 99%